Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Aclaris Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 127 | 1 | 128 | +2 |
| Shares | 63.6M | 68 | 65.8M | +2.23M (+3.5%) |
| Value | $1.00B | $1.00K | $1.04B | +$35.7M (+3.6%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Braidwell LP | 2,393,985 | $37.7M | 1.26% |
| Cheyne Capital Management (UK) LLP | 50,964 | $802.7K | 1.42% |
| HRT Financial LP | 45,535 | $717.0K | 0.01% |
| Alps Advisors Inc | 45,205 | $712.0K | 0.01% |
| Handelsbanken Fonder AB | 14,800 | $233.0K | 0.00% |
| ExodusPoint Capital Management, LP | 14,753 | $232.0K | 0.00% |
| Algert Global LLC | 13,830 | $217.8K | 0.01% |
| XTX Topco Ltd | 12,423 | $195.7K | 0.04% |
| Two Sigma Investments, LP | 10,700 | $168.5K | 0.00% |
| Aquatic Capital Management LLC | 8,800 | $139.0K | 0.01% |
| State of Wyoming | 5,533 | $87.1K | 0.03% |
| Point72 Middle East FZE | 4,788 | $75.4K | 0.01% |
| Quarry LP | 1,124 | $17.7K | 0.02% |
Sold out (11)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Affinity Asset Advisors, LLC | 136,434 | $2.15M |
| UBS Oconnor LLC | 113,426 | $1.78M |
| Requisite Capital Management, LLC | 45,000 | $708.0K |
| Susquehanna International Group, LLP | 22,536 | $355.0K |
| AXA S.A. | 18,200 | $286.5K |
| Ensign Peak Advisors, Inc | 15,950 | $251.0K |
| Campbell & CO Investment Adviser LLC | 13,771 | $217.0K |
| Cubist Systematic Strategies, LLC | 8,109 | $128.0K |
| Macquarie Group Ltd | 1,568 | $25.0K |
| High Net Worth Advisory Group LLC | 500 | $8.00K |
| Group One Trading, L.P. | 457 | $7.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 68 | $1.00K |